Go to deals
Healthcare

Orthos Europe has been acquired by Atrium Innovations

September 2008 — Holland Venture has sold Orthos Europe to Atrium Innovations.

Orthos Europe’s main brand is AOV under which high-quality food supplements such as multi-vitamins, minerals, probiotics, enzymes, fatty acids and antioxidants are developed and marketed. The company was founded over 20 years ago and has a very strong position in the Netherlands, where it is a leading player in its market segment.

Atrium Innovations is a developer, manufacturer and marketer of science-based and professionally endorsed products for the health and nutrition industries. Atrium markets a portfolio of finished products through its sales and marketing network in more than 35 countries, primarily in North America and Europe.

Holland Venture is an independent private equity fund located in Amsterdam. Since 1981, Holland Venture has realized the growth potential of many of its investments and has proven to be a trustworthy partner.

Our role in the transaction

Oaklins' team in the Netherlands advised the seller in this transaction.

Parties

Talk to the deal team

Maarten Wolleswinkel

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Related deals

UKAT Group has acquired Bayberry Limited
Private Equity | Healthcare

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Learn more
Medicija has acquired Saulės Šeimos Medicinos Centras
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Learn more
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more